Pigmented Villonodular Synovitis: Clinical Trials

2 trials for Pigmented Villonodular Synovitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Completed 1

Follow Pigmented Villonodular Synovitis: new trials by email Literature Review of Pigmented Villonodular Synovitis trials Research Report on Pigmented Villonodular Synovitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Vimseltinib - Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis
Phase 1 / Phase 2Active not recruitingDeciphera Pharmaceuticals, LLC1202017-02-162026-06-25
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
FPA008 - Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor
Phase 1 / Phase 2CompletedFive Prime Therapeutics, Inc.662015-06-012021-08-31

Narrower conditions

Giant Cell Tumor of Tendon Sheath (2)  ·  Synovitis, Pigmented Villonodular (2)

Broader conditions

Giant Cell Tumors (2)  ·  Joint Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Synovitis (2)  ·  Tendinopathy (2)

Interventions

cabiralizumab (1)

Sponsors

Deciphera Pharmaceuticals, LLC (1)  ·  Five Prime Therapeutics, Inc. (1)

Countries

France (2)  ·  Netherlands (2)  ·  Poland (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Maitreyi Sharma, MD (1)